as per annexure enclosed
Awaiting price reaction for this filing.
Apollo Hospitals reported its audited consolidated FY25 results, with revenue from operations rising about 14% year-on-year to Rs 21,794 crore and profit after tax jumping roughly 61% to Rs 1,505 crore (from Rs 935 crore in FY24). On a standalone basis, revenue grew about 13% to Rs 8,202 crore and PAT grew about 28% to Rs 1,296 crore, with EBITDA improving to Rs 2,044 crore. The Board recommended a final dividend of Rs 10 per share (200%), taking total FY25 dividend to Rs 19 per share (380%), with a record date of August 19, 2025. The Board also approved acquiring an existing 200-bed hospital for around Rs 285 crore, re-appointed Executive Directors and Independent Director Mr. Som Mittal, and appointed new Secretarial Auditors for five years. Statutory auditors Deloitte Haskins & Sells LLP issued an unmodified opinion on the results.
Strong earnings growth, especially on the consolidated side, along with a healthy dividend should be positive for shareholders. The hospital acquisition signals continued capacity expansion, while the higher borrowings visible on the consolidated balance sheet (long-term borrowings nearly doubled to Rs 4,417 crore) is worth monitoring.